MedPath

Periodontitis treatment in patients with reumatoid arthritis and high clinical activity in the. Randomized clinical trial.

Phase 1
Conditions
Patients with rheumatoid arthritis with high clinical activity and chronical peirodontitis moderate-severe.
MedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Registration Number
EUCTR2017-003259-40-ES
Lead Sponsor
Dra Beatriz Lozano-Hospital Universitario de Canarias
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients more than 18 years with RA (ACR/EULAR 2010 criteria) with high clinical activity defined SG) y/o DAS28 (PCR)> 5,1 y SDAI > 26.
Ptients with moderate-severe chronic peridontitis (Level 2 Tonetti 2005)
Paients with 8 teeth and more than 8 teeth.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40

Exclusion Criteria

Non-surgical periodontal treatment during the previous 6 months
Oral surgical treatment during the previous 12 months
Antibiotic treatment in the previous 6 months
Pre-treatment with cyclosporin-A, calcium channel blockers or phenytoin.
Requirement of antibiotic prophylaxis prior to oral examination.
Patients with RA who carry any prosthetic joint replacement.
Patients who collaborate and who are able to sign informed consent.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath